Fewer Than Half of U.S. Pharmacies Carry One of the Most Effective Drugs for Opioid Abuse

A pharmacist holding a box of medication.
June 13, 2022
Tara Law from Time writes about how few pharmacies carry buprenorphine, a life-saving drug to help treat opioid use disorder (OUD). Lucas Hill, Pharm.D., BCACP, director of the college's Pharmacy Addictions Research & Medicine (PhARM) program, offers his insight on the issue, and how the DEA's crackdown of the drug puts OUD patients at risk.

Pharmacy Students Report Both Motivators, Barriers to Attending Class Pre-, Post-Pandemic

Pie charts.
December 7, 2021
Student pharmacist Cara Rutledge (Pharm.D. Class of 2022) wrote an article for the Pharmacy Times about her honors program thesis which aimed to address the various complexities of student motivation, engagement and attendance in relation to mastery of course material.

UT Pharmacy Students Reflect on the Pandemic, Look to the Future

A person typing on a laptop in their house.
December 1, 2021
UT student pharmacists Kailee Marikar, Sadaf Helforoosh, Hannah McCullough, Agaustin Wong and Cara Rutledge talked to the Pharmacy Times’ Skylar Kenney about their experiences balancing their studies in the midst of the pandemic and how COVID-19 showed a pharmacist's vital role in public health.

Opioid Use Disorder Paper Earns ACCP Award

A box of naloxone vials.
October 8, 2021
A paper from UT College of Pharmacy researchers was awarded the 2021 Outstanding Paper of the Year from the American College of Clinical Pharmacy (ACCP) Ambulatory Care Practice Research Network. The paper investigates the availability of buprenorphine and naloxone in Texas to treat opioid use disorder.

3D-Printing Project Aims to Meet UT Community’s PPE Needs

face sheild visors in bulk
April 8, 2020
Mo Maniruzzaman‘s Pharmaceutical Engineering and 3D Printing (PharmE3D) Lab is 3D-printing face shields to meet PPE demands at UT health institutions during the COVID-19 pandemic.